Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines

被引:62
|
作者
Nakanishi, Y [1 ]
Kamijo, R [1 ]
Takizawa, K [1 ]
Hatori, M [1 ]
Nagumo, M [1 ]
机构
[1] Showa Univ, Sch Dent, Dept Oral & Maxillofacial Surg 2, Ota Ku, Tokyo 1458515, Japan
关键词
U-937; ML-1; COX-2; inhibitor; NS-398; nabumetone; proliferation; differentiation; G0/G1; arrest;
D O I
10.1016/S0959-8049(01)00160-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostaglandins (PG) are known to play important roles in the proliferation and differentiation of leukaemia cells. The effect of the inhibitors of cyclooxygenase-2 (COX-2), a rate-limiting enzyme for the synthesis of PG, on the proliferation and differentiation of leukaemia cell lines was investigated. COX-2 inhibitors, NS-398 and nabumetone, suppressed the proliferation of U-937 and ML-1 cells by inducing a G0/G1 cell-cycle arrest. Cell-cycle arrest induced by these COX-2 inhibitors was not associated with an upregulation of the cyclin-dependent kinase inhibitors. COX-2 inhibitors also inhibited the differentiation of these cells induced by interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and retinoic acid (RA). Treatment with NS-398 did not suppress the levels of PGs produced by these cells. Although COX-2 antisense oligonucleotide showed a similar inhibitory effect on these cells, its inhibitory effect was smaller than that of NS-398, These results suggest that COX-2 inhibitors may suppress the proliferation and differentiation of leukaemia cells both via COX-2-dependent and -independent pathways. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1570 / 1578
页数:9
相关论文
共 50 条
  • [1] Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation
    Srinath, P
    Rao, PNP
    Knaus, EE
    Suresh, MR
    ANTICANCER RESEARCH, 2003, 23 (5A) : 3923 - 3928
  • [2] The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines
    J P de Souza Filho
    Z M S Correa
    J C Marshall
    E Anteka
    A B Coutinho
    M C Martins
    Eye, 2006, 20 : 598 - 601
  • [3] The effect of a selective cyclooxygenase-2 (COX-2) inhibitor on the proliferation rate of retinoblastoma cell lines
    de Souza, JP
    Correa, ZMS
    Marshall, JC
    Anteka, E
    Coutinho, AB
    Martins, MC
    Burnier, MN
    EYE, 2006, 20 (05) : 598 - 601
  • [4] Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
    Lombardi, Francesca
    Augello, Francesca Rosaria
    Artone, Serena
    Gugu, Mitilda Karoli
    Cifone, Maria Grazia
    Cinque, Benedetta
    Palumbo, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [5] Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy
    Milas, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : S66 - S69
  • [6] Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
    Li, Shuangshuang
    Jiang, Min
    Wang, Lu
    Yu, Shuwen
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [7] 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
    Talley, JJ
    Bertenshaw, SR
    Brown, DL
    Carter, JS
    Graneto, MJ
    Koboldt, CM
    Masferrer, JL
    Norman, BH
    Rogier, DJ
    Zweifel, BS
    Seibert, K
    MEDICINAL RESEARCH REVIEWS, 1999, 19 (03) : 199 - 208
  • [8] Cancer and cyclooxygenase-2 (COX-2) inhibition
    Evans, JF
    Kargman, SL
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (06) : 627 - 634
  • [9] Cyclooxygenase-2 (COX-2) Expression in Equine Melanocytic Tumors
    Pimenta, Jose
    Prada, Justina
    Pires, Isabel
    Cotovio, Mario
    VETERINARY SCIENCES, 2024, 11 (02)
  • [10] Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer
    Buecher, B
    Heymann, MF
    Blottière, HM
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (11): : 967 - 978